Neuroleptic malignant syndrome controversies revisited—what is the incidence of neuroleptic malignant syndrome?

Authors


R. Gurrera, Mental Health, VA Boston Healthcare System, 940 Belmont Street (116A), Brockton, MA 02301, USA. E-mail: ronald_gurrera@hms.harvard.edu

No abstract is available for this article.

Ancillary